LeonaBio (LONA) Free Cash Flow (2019 - 2026)

LeonaBio (LONA) has reported Free Cash Flow for 8 consecutive years, with -$20.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Free Cash Flow fell 42.54% year-over-year to -$20.9 million; the TTM figure through Mar 2026 stood at -$52.0 million (up 39.61% YoY), while the FY2025 annual figure was -$45.7 million, up 52.96% from the prior year.
• Free Cash Flow slipped to -$20.9 million in Q1 2026 per LONA's latest filing, from -$19.4 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$4.7 million in Q3 2025 and bottomed at -$26.4 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$19.9 million across 5 years, with a median of -$21.9 million in 2022.
• Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 144.09% — and 2025, when it soared 79.72%.
• LeonaBio's Free Cash Flow stood at -$15.7 million in 2022, then sank by 67.81% to -$26.3 million in 2023, then rose by 1.06% to -$26.0 million in 2024, then gained by 25.43% to -$19.4 million in 2025, then slipped by 7.76% to -$20.9 million in 2026.
• Business Quant data shows LONA's Free Cash Flow at -$20.9 million in Q1 2026, -$19.4 million in Q4 2025, and -$4.7 million in Q3 2025.